<i>TP53</i> missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment
Martino Maddalena(Weizmann Institute of Science), Moshe Oren(Weizmann Institute of Science), Ron Rotkopf(Weizmann Institute of Science), Saptaparna Mukherjee(Weizmann Institute of Science), Ravid Straussman(Weizmann Institute of Science), Giuseppina Lambiase(Weizmann Institute of Science), Yosef Yarden(Weizmann Institute of Science), Giuseppe Mallel(Weizmann Institute of Science), Bianca Pellegrino(Weizmann Institute of Science), Raya Eilam(Weizmann Institute of Science), Eyal Ben-Isaac(Weizmann Institute of Science), Yoseph Addadi(Weizmann Institute of Science), Abby Kapsack(Weizmann Institute of Science), Michal Lotem(Hadassah Medical Center), Ori Hassin(Weizmann Institute of Science), Michal Shreberk‐Shaked(Weizmann Institute of Science), Sharathchandra Arandkar(Tata Memorial Hospital), Nishanth Belugali Nataraj(Weizmann Institute of Science), Emma Hajaj(Hadassah Medical Center), Ofra Golani(Weizmann Institute of Science)
Cited by 113
Related Papers
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
|Nature|2012|1.7k
Decision making by p53: life, death and cancer
|Cell Death and Differentiation|2003|1.1k
c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor
|Genes & Development|1998|861
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage
|Genes & Development|2001|702